Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists

Bioorganic & Medicinal Chemistry
2012.0

Abstract

On the basis of a marine fungal phthalide (paecilocin A) skeleton, we synthesized 20 analogs and evaluated them for peroxisome proliferator-activated receptor gamma (PPAR-γ) binding and activation. Among these analogs, 6 and 7 had significant PPAR-γ binding activity, and 7 showed further PPAR-γ activation in rat liver Ac2F cells. In docking simulation, 7 formed H bonds with key amino acid residues of the PPAR-γ binding domain, and the overall positioning was similar to rosiglitazone. This new phthalide derivative is considered an interesting new molecular class of PPAR-γ ligands.

Knowledge Graph

Similar Paper

Design and synthesis of marine fungal phthalide derivatives as PPAR-γ agonists
Bioorganic & Medicinal Chemistry 2012.0
Design, synthesis, and biological activity of novel PPARγ ligands based on rosiglitazone and 15d-PGJ2
Bioorganic & Medicinal Chemistry Letters 2005.0
PPAR-γ Agonistic Metabolites from the Ascidian <i>Herdmania momus</i>
Journal of Natural Products 2012.0
PPAR-γ Agonistic Metabolites from the Ascidian <i>Herdmania momus</i>
Journal of Natural Products 2012.0
Identification of (β-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor γ activity
European Journal of Medicinal Chemistry 2010.0
Plakilactones from the Marine Sponge<i>Plakinastrella mamillaris</i>. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor γ
Journal of Medicinal Chemistry 2012.0
Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling
European Journal of Medicinal Chemistry 2008.0
Synthesis and biological activity of a novel series of indole-derived PPARγ agonists
Bioorganic &amp; Medicinal Chemistry Letters 1999.0
Synthesis and evaluation of a series of benzopyran derivatives as PPAR α/γ agonists
European Journal of Medicinal Chemistry 2008.0
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffold
Bioorganic &amp; Medicinal Chemistry 2019.0